Where will genetically modified mosquitoes be tested?

Phase 1 studies can be conducted in appropriately contained laboratory and cage facilities anywhere, as long as the mosquito species of interest can be maintained there. All field studies and trials will necessarily have to be conducted in environments where the target mosquito species exists naturally. Phase 3 testing, which measures safety and efficacy for reducing disease, must be conducted in areas where the disease of interest is actively transmitted.